Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Xcelience, a provider of formulation development, drug preformulation and analytical services, is set to add four new manufacturing equipment and a new automated packaging line to enhance its clinical trial supplies manufacturing and packaging capabilities.
Subscribe to our email newsletter
As part of its expansion program, Xcelience has currently included a MG Futura (capsule-filling machine for powder and pellets), LCI Multi-granulator MG-55 (extruder), QJ-230T marumerizer (spheronizer), and wurster insert (bottom spray) to the existing Glatt GPCG-3 fluid bed processor.
Further, the company has also included a packaging line (including ink-jet coding) for primary bottling of tablets and capsules.
Xcelience Operations director Theodore Koontz said the addition of the MG Futura improves production times, increases overall capacity, and expands upon their existing capabilities for powders, pellets and powder micro-dosing for inhalation systems.